IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
21 hedge funds and large institutions have $894K invested in Interpace Biosciences, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$77.5K | |
| 2 | +$16.7K | |
| 3 | +$8.68K | |
| 4 |
Renaissance Technologies
New York
|
+$6.55K |
| 5 |
Goldman Sachs
New York
|
+$1.13K |
Top Sellers
| 1 | -$89.6K | |
| 2 | -$2.76K | |
| 3 | -$1.35K | |
| 4 |
Bank of New York Mellon
New York
|
-$691 |
| 5 |
Morgan Stanley
New York
|
-$28 |